CH652930A5 - Polysaccharid-agglomerat. - Google Patents
Polysaccharid-agglomerat. Download PDFInfo
- Publication number
- CH652930A5 CH652930A5 CH1647/83A CH164783A CH652930A5 CH 652930 A5 CH652930 A5 CH 652930A5 CH 1647/83 A CH1647/83 A CH 1647/83A CH 164783 A CH164783 A CH 164783A CH 652930 A5 CH652930 A5 CH 652930A5
- Authority
- CH
- Switzerland
- Prior art keywords
- agglomeration
- polysaccharide
- agglomerate according
- polysaccharide agglomerate
- carrier
- Prior art date
Links
- 150000004676 glycans Chemical class 0.000 title claims description 13
- 229920001282 polysaccharide Polymers 0.000 title claims description 13
- 239000005017 polysaccharide Substances 0.000 title claims description 13
- 244000303965 Cyamopsis psoralioides Species 0.000 claims description 17
- 229920000926 Galactomannan Polymers 0.000 claims description 14
- 238000005054 agglomeration Methods 0.000 claims description 14
- 230000002776 aggregation Effects 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims description 9
- 235000013312 flour Nutrition 0.000 claims description 9
- 230000008961 swelling Effects 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 5
- 235000013311 vegetables Nutrition 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 210000002011 intestinal secretion Anatomy 0.000 claims description 3
- 210000003097 mucus Anatomy 0.000 claims description 3
- 235000012015 potatoes Nutrition 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 230000003111 delayed effect Effects 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229920002907 Guar gum Polymers 0.000 claims 1
- 229920000161 Locust bean gum Polymers 0.000 claims 1
- 238000004040 coloring Methods 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 239000000711 locust bean gum Substances 0.000 claims 1
- 235000010420 locust bean gum Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000037356 lipid metabolism Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 244000141359 Malus pumila Species 0.000 description 2
- 229960000516 bezafibrate Drugs 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000000563 Hyperlipoproteinemia Type II Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 206010045254 Type II hyperlipidaemia Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004204 exocrine pancreatic function Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229960004580 glibenclamide Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- DQDAYGNAKTZFIW-UHFFFAOYSA-N phenprocoumon Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC)C1=CC=CC=C1 DQDAYGNAKTZFIW-UHFFFAOYSA-N 0.000 description 1
- 229960004923 phenprocoumon Drugs 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/14—Hemicellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1647/83A CH652930A5 (de) | 1983-03-25 | 1983-03-25 | Polysaccharid-agglomerat. |
| DE19843409400 DE3409400A1 (de) | 1983-03-25 | 1984-03-14 | Polysaccharid-agglomerat |
| GB08407464A GB2139469B (en) | 1983-03-25 | 1984-03-22 | Galactomannan containing compositions |
| US06/592,489 US4675312A (en) | 1983-03-25 | 1984-03-23 | Polysaccharide agglomerate and method of preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1647/83A CH652930A5 (de) | 1983-03-25 | 1983-03-25 | Polysaccharid-agglomerat. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH652930A5 true CH652930A5 (de) | 1985-12-13 |
Family
ID=4215348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1647/83A CH652930A5 (de) | 1983-03-25 | 1983-03-25 | Polysaccharid-agglomerat. |
Country Status (4)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE458576B (sv) * | 1985-06-20 | 1989-04-17 | Lejus Medical Ab | Foerfarande foer framstaellning av en guar-gum produkt |
| DE3613219A1 (de) * | 1986-04-18 | 1987-10-22 | Speck Ulrich | Guar-mehl |
| DE69823315D1 (de) * | 1997-11-20 | 2004-05-27 | Armengol Hermanos S A | Verfahren zur Herstellung von granulierter Johannisbrotpulpe oder Tierfutter oder rohes Futtermaterial hergestellt nach diesem Verfahren |
| ES2136038B1 (es) * | 1998-02-03 | 2000-07-01 | Consejo Superior Investigacion | Fibra dietetica conteniendo galactomananos. |
| JP2007524690A (ja) * | 2004-02-17 | 2007-08-30 | ヴェーリ・インター・アーゲー | 活性物質の生体内利用効率を高めるためのガラクトマンナン及び／又はグルコマンナン |
| DE102004008017A1 (de) * | 2004-03-17 | 2005-11-03 | Wheli Inter Ag | Anwendung von Polysacchariden wie Galaktomannane, Glucomannane und dergleichen zur Einschleusung von Wirkstoffen, insbesondere dem menschlichen Wachstumshormons HGH in den menschlichen oder tierischen Stoffwechsel |
| US20050181058A1 (en) * | 2004-02-17 | 2005-08-18 | Andreas Hefel | Use of polysaccharides, such as galactomannans, glucomannans and the like for introducing active substances into the human or animal metabolism |
| EP2031975A1 (en) | 2006-05-24 | 2009-03-11 | Vitality Concepts Corporation | Method for embedding and targeted release of micronutrients in activated dietary fibers |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA581296A (en) * | 1959-08-11 | W. Elverum Gerard | Guar process | |
| DE285153C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1900-01-01 | |||
| US2992188A (en) * | 1957-02-19 | 1961-07-11 | Kelco Co | Water dispersible gum product and method |
| DE1193786B (de) * | 1958-03-12 | 1965-05-26 | Gen Mills Inc | Verfahren zur Verbesserung der Dispergierbarkeit feinteiliger Pflanzengummiteilchen |
| CH382537A (fr) * | 1959-09-16 | 1964-09-30 | Wander Ag Dr A | Procédé de fabrication d'une farine à faible pouvoir calorifique |
| US3042668A (en) * | 1960-12-02 | 1962-07-03 | American Molasses Company | Modified galactomannan gums and method of preparing same |
| DE1193876B (de) * | 1962-02-23 | 1965-05-26 | Internat Harvester Company M B | Selbsttragende Abstuetzung fuer vom Schlepper geloeste Frontladeschwingen |
| GB1041600A (en) * | 1963-12-13 | 1966-09-07 | Sandoz Products Ltd | Dieting and sandwich biscuits |
| US3455899A (en) * | 1966-08-01 | 1969-07-15 | Gen Mills Inc | Production of low odor,low taste galactomannan gums |
| US4053638A (en) * | 1970-05-06 | 1977-10-11 | William Wrigley Jr. Company | Anticaries confectioneries and oral health products |
| US3953615A (en) * | 1971-08-03 | 1976-04-27 | The Coca-Cola Co. | Hydration drying of coffee, tea, or juice concentrate by means of anhydrous dextrose |
| US3998974A (en) * | 1972-10-25 | 1976-12-21 | Dynapol Corporation | Comestibles containing non-nutritive flavoring |
| DE2434112A1 (de) * | 1973-10-22 | 1975-04-24 | Klosterfrau Berlin Chem | Verfahren zur herstellung eines trockenen, fette, proteine und kohlenhydrate enthaltenden nahrungsmittelpulvers |
| US4112220A (en) * | 1974-10-29 | 1978-09-05 | Imc Chemical Group, Inc. | Nitrate esters of galactomannan gums and methods for their synthesis |
| US4031305A (en) * | 1975-11-17 | 1977-06-21 | Celanese Corporation | Polygalactomannan ether compositions |
| US4156021A (en) * | 1976-03-03 | 1979-05-22 | Maxfibe, Inc. | Oleaginous fibrous simulated food product |
| FI783405A7 (fi) * | 1977-12-22 | 1979-06-23 | Stamag | Huvudsakligen av kli bestaoende bakverk och foerfarande foer dess framstaellning |
| GB2022391B (en) * | 1978-05-30 | 1982-10-20 | Speywood Lab Ltd | Bread containing gum and its manufacture |
| EP0007619B1 (en) * | 1978-07-25 | 1983-06-22 | The Wellcome Foundation Limited | Galactomannan polysaccharide gum formulation containing gellation inhibitor |
| JPS5774072A (en) * | 1980-10-29 | 1982-05-10 | Yamanouchi Pharmaceut Co Ltd | Granule of dietary fiber and its preparation |
| DE3139920A1 (de) * | 1981-10-08 | 1983-04-28 | Nittner, Erich, Dr., 8280 Kreuzlingen | "mittel in granulatform auf basis von polysaccharid-gummen, verfahren zu seiner herstellung und verwendung" |
| DE3147268A1 (de) * | 1981-11-28 | 1983-06-16 | Boehringer Mannheim Gmbh, 6800 Mannheim | Oral applizierbare zubereitungsformen von guar-mehl |
| DE3208768A1 (de) * | 1982-03-11 | 1983-09-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Aromatisierte guar-mehl-tabletten |
| US4496606A (en) * | 1983-04-29 | 1985-01-29 | Nabisco Brands, Inc. | Guar gum food bar |
-
1983
- 1983-03-25 CH CH1647/83A patent/CH652930A5/de not_active IP Right Cessation
-
1984
- 1984-03-14 DE DE19843409400 patent/DE3409400A1/de active Granted
- 1984-03-22 GB GB08407464A patent/GB2139469B/en not_active Expired
- 1984-03-23 US US06/592,489 patent/US4675312A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GB8407464D0 (en) | 1984-05-02 |
| GB2139469B (en) | 1987-04-08 |
| GB2139469A (en) | 1984-11-14 |
| DE3409400A1 (de) | 1984-10-04 |
| DE3409400C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-07-09 |
| US4675312A (en) | 1987-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Msomi et al. | Suitability of sugar alcohols as antidiabetic supplements: A review | |
| Zunft et al. | Carob pulp preparation for treatment of hypercholesterolemia | |
| Salas-Salvadó et al. | Dietary fibre, nuts and cardiovascular diseases | |
| Coudray et al. | Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men | |
| US5126143A (en) | Bowel movement-improving food products | |
| DE60209442T2 (de) | Phaseolamin-Zusammensetzungen und Verfahren zur Anwendung derselben | |
| CN111011862A (zh) | 一种食用组合物、低血糖生成指数营养粉及其制备方法 | |
| DE69002482T2 (de) | Wasserlösliche diätetische Fasern und Verfahren zu ihrer Herstellung. | |
| CN114403403B (zh) | 一种具有减脂减重功效的果冻及其制备方法 | |
| DE60224513T2 (de) | Cactacea zubereitung mit fettbindenden eigenschaften, sowie verfahren ihrer herstellung | |
| CN102106393B (zh) | 一种富含纤维素的乳制品及其制备方法 | |
| DE2821015A1 (de) | Diaetetisches praeparat | |
| DE3319575C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| CH652930A5 (de) | Polysaccharid-agglomerat. | |
| CN107212416A (zh) | 一种糖尿病全营养配方食品的制备方法及应用 | |
| DE3216514A1 (de) | Cellulose/carboxymethylcellulose-mischungen zur kontrolle der faekalausscheidung und deren verwendung | |
| DE102010038644A1 (de) | Diätetische, nahrungsergänzende Zusammensetzung | |
| DE602004000665T2 (de) | Biologisches Verfahren zur Herstellung eines Hämeisenpräparats und daraus hergestellte Nahrungsmittelprodukte | |
| KR20010103065A (ko) | 식이섬유 함유 다이어트 조성물 | |
| DE69521200T2 (de) | Formulierung von energie | |
| EP2048969B1 (de) | Fraktionen aus molkepermeat und deren verwendung zur prävention und therapie des typ-2 diabetes und des metabolischen syndroms | |
| CN101060854B (zh) | 具有抗糖尿病作用的蛋白质水解物 | |
| DE69522723T2 (de) | Antiallergisches Mittel und Nährstoffzusammensetzung, die Glutamin enthalten | |
| DE69232126T2 (de) | Aufnehmbare Zubereitungen enthaltend wasserlösliche, hochviskose Cellulosether | |
| CH650129A5 (en) | Granular polysaccharide preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |